America’s poorest seniors could soon find it much harder to get the medicines they need.
That’s because Medicare’s Low-Income Subsidy program — which provides millions of seniors with prescription drug coverage that comes with no monthly premium — is eroding. And recent changes made in the Inflation Reduction Act are partly to blame.
The number of “benchmark” LIS plans — which offer coverage without a monthly premium — plummeted 34% last year alone. As a result of some plans being discontinued or increasing their monthly premium, over 1.3 million seniors were reassigned to a different plan by the Centers for Medicare & Medicaid Services, or CMS. Many other seniors had no choice but to opt for more expensive alternative plans that require monthly premiums, jeopardizing their access to life-saving medicines — or reducing what they can spend on other necessities like groceries and rent.
The Low-Income Subsidy program is a lifeline for roughly 13 million Americans.
Low-income seniors are disproportionately burdened by chronic health conditions like diabetes and heart disease, so whether they can afford prescriptions can be a matter of life and death.
Only seniors whose annual earnings are less than 150% of the federal poverty line — about $22,500 for a single person or $30,500 for a couple — qualify for the program.
By the numbers, communities of color are especially reliant on these subsidies.
Combined, Black and Hispanic beneficiaries make up just 20% of Medicare drug plan enrollees. But within the subsidy program, Black and Hispanic beneficiaries total 37% of enrollees.
At the same time, minority seniors tend to experience more negative health outcomes when compared to their Anglo counterparts. The data show that Black and Hispanic Medicare subscribers have higher hospitalization rates and an increased likelihood of suffering from chronic conditions like hypertension.
That’s what makes the sharp reduction in Medicare’s low-income subsidy plans so alarming. The decline is, in part, the result of changes made to the Part D program in the Inflation Reduction Act.
Low-income subsidy enrollees are increasingly having to turn to higher-premium plans.
The number who now have to pay premiums has increased by more than 1 million just since last year.
The financial burden on seniors varies by state. As two examples, Medicare drug-plan premiums within the low-income subsidy group can exceed $155 in West Virginia and Pennsylvania.
Just as concerning is the fact that premiums across all Medicare prescription drug plans are rising. Average monthly premiums are projected to increase by at least 21% by the end of this year.
It’s a concerning situation. Without swift action from CMS and Congress, America’s poorest seniors risk losing access to the medicines they need to live healthy lives.
Dr. Yanira Cruz is the president and CEO of the National Hispanic Council on Aging. This piece originally ran in Medical Economics.
